Oncology Central

Breast cancer screening: past, present and future


Ironically, improvements in breast cancer therapy and screening technology are very likely diminishing the benefit of mammography screening. Therapeutic advances are reducing both the relative and absolute benefit of mammography screening on breast cancer specific mortality, while advances in imaging technology are increasing the risk of overdiagnosis and hence the risk of a small excess in mortality from unnecessary diagnostic and therapeutic interventions. Alternatives to mammography screening should be considered, particularly in older women, for whom the risk of overdiagnosis is substantial.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.